ArticleCardiorenal medicine2024

Denosumab Decreases Epicardial Adipose Tissue Attenuation in Dialysis Patients with Secondary Hyperparathyroidism and Low Bone Mass.

Chien-Liang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.